“Clinical Use, Safety and Effectiveness of Novel High Cost Anticancer Therapies After Marketing Approval: A Record Linkage Study”. Epidemiology, Biostatistics, and Public Health, vol. 10, no. 3, July 2022, https://doi.org/10.2427/9016.